Puma Biotechnology Stock Forward View - Daily Balance Of Power

PBYI Stock  USD 6.21  -0.01  -0.16%   
As of today, the 14-period RSI for Puma Biotechnology is 0, signaling extreme oversold conditions. Readings below 20 are commonly associated with potential stabilization zones.
Momentum 47
 Impartial
 
Oversold
 
Overbought
The successful prediction of Puma Biotechnology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Puma Biotechnology, which may create opportunities for some arbitrage if properly timed. Key fundamental drivers for Puma Biotechnology's price forecast:
 Quarterly Earnings Growth
-0.34
 EPS Estimate Next Quarter
0.04
 EPS Estimate Current Year
0.4
 EPS Estimate Next Year
0.65
 Wall Street Target Price
5
This view frames how Puma Biotechnology responds to recent headlines and peer activity within its market context. Sentiment is summarized using Puma Biotechnology's options positioning and short interest activity.

Puma Biotechnology Short Interest

A significant increase or decrease in Puma Biotechnology's short interest from the previous month could be a good indicator of investor sentiment towards Puma. Short interest can provide insight into the potential direction of Puma Biotechnology stock and how bullish or bearish investors.
 200 Day MA
4.9804
 Short Percent
0.085
 Short Ratio
8.57
 Shares Short Prior Month
3.5 M
 50 Day MA
6.5036

Puma Relative Strength Index

Puma Biotechnology Hype to Price Pattern

Investor biases related to Puma Biotechnology's public news can be used to forecast risks associated with an investment in Puma. The trend in average sentiment can be used to explain how an investor holding Puma can time the market purely based on public headlines and social.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Puma Biotechnology's market sentiment to its price can help traders make decisions based on the overall investor consensus about Puma Biotechnology.
Puma Biotechnology Implied Volatility
    
  2.27  
Puma Biotechnology's implied volatility exposes the market's sentiment of Puma Biotechnology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Puma Biotechnology's implied volatility is high, the market thinks the stock has potential.
Puma Biotechnology after-hype prediction price
    
  USD 6.26  
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of Puma Biotechnology to cross-verify projections for Puma Biotechnology. The view provides historical context for the projection set.
For information on how to trade Puma Stock refer to our How to Trade Puma Stock guide.

Open Interest for Puma 2026-04-17 Options

Open interest counts active option contracts on Puma Biotechnology, providing a view of participation and positioning in the options market. It adds context to volatility and price behavior.

Puma Biotechnology Additional Predictive Modules

Most predictive techniques to examine Puma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Puma using various technical indicators. When you analyze Puma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Puma Biotechnology has current Daily Balance Of Power of 0. Balance of Power indicator (or BOP) measures the strength of Puma Biotechnology market sensitivity to bulls and bears. It estimates the ability of Puma Biotechnology buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Puma Biotechnology Balance of Power indicator one can determine a trend of the price direction.
Check Puma Biotechnology VolatilityBacktest Puma BiotechnologyInformation Ratio  

Puma Biotechnology Trading Date Momentum

On March 10 2026 Puma Biotechnology was traded for 6.21 at the closing time. The top price for the day was 6.21 and the lowest listed price was 6.21 . There was no trading activity during the period 0.0. Lack of trading volume on March 10, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.16% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Puma Biotechnology to competition

Other Forecasting Options for Puma Biotechnology

For every potential investor in Puma, whether a beginner or expert, Puma Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.

Puma Biotechnology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Puma Biotechnology stock to make a market-neutral strategy. Peer analysis of Puma Biotechnology could also be used in its relative valuation, which is a method of valuing Puma Biotechnology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Puma Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Puma Biotechnology shares will generate the highest return on.

Puma Biotechnology Risk Indicators

The analysis of Puma Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Puma Biotechnology's investment and either accepting that risk or mitigating it.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Puma Biotechnology

Coverage intensity for Puma Biotechnology matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Puma Biotechnology Short Properties

Short sentiment tied to Puma Biotechnology matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding50.7 M
Cash And Short Term Investments97.5 M

More Resources for Puma Stock Analysis

A structured review of Puma Biotechnology often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Puma Biotechnology Stock. Outlined below are key reports that provide context for Puma Biotechnology Stock:
Use Historical Fundamental Analysis of Puma Biotechnology to cross-verify projections for Puma Biotechnology. The view provides historical context for the projection set.
For information on how to trade Puma Stock refer to our How to Trade Puma Stock guide.
Analysis related to Puma Biotechnology should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
 Quarterly Earnings Growth
-0.34
 Earnings Share
0.61
 Revenue Per Share
4.566
 Quarterly Revenue Growth
0.277
 Return On Assets
0.1085
The market value of Puma Biotechnology is measured differently than book value, which reflects Puma accounting equity. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Market price can move with sentiment, cycles, and liquidity conditions, so it may drift away from fundamentals. Valuation methods compare these perspectives to frame context.
Note that Puma Biotechnology's intrinsic value and market price are different measures derived from different inputs. Analysis often considers earnings, revenue quality, fundamentals, technical signals, competition, and analyst coverage. By contrast, market price reflects the level where buyers and sellers transact.